KARYOPHARM THERAPEUTICS INC - NOTE 3.000%10/1

Historical Holders from Q4 2019 to Q4 2024

CUSIP
48576UAA4
Type / Class
Debt / NOTE 3.000%10/1
All holders as of December 31, 2024
Q4 2024
Principal, excl. options
23.4M
Holdings value
$18.2M
% of all portfolios
0%
Grand Portfolio weight change
0%
Number of holders
5
Number of buys
1
Number of sells
-1
Average Value change %
+0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of KARYOPHARM THERAPEUTICS INC - NOTE 3.000%10/1

Period Principal Value Change Price Investors
2024 Q4 $23.4M $18.2M -$20.4K $0.78 5
2024 Q3 $23.4M $17.5M +$1.52M $0.77 6
2024 Q2 $21.4M $13.7M -$77.8M $0.65 5
2024 Q1 $151M $93.9M -$11.7B $0.54 11
2023 Q4 $170M $86M +$10.9M $0.50 11
2023 Q3 $148M $108M $0 $0.64 11
2023 Q2 $148M $114M -$1.43M $0.68 11
2023 Q1 $177M $151M +$337K $0.77 11
2022 Q4 $157M $129M -$510K $0.76 9
2022 Q3 $91.4M $83.8M -$1.74M $0.81 8
2022 Q2 $101M $78.8M -$54.5M $0.73 10
2022 Q1 $162M $148M +$2.01M $0.84 18
2021 Q4 $161M $144M -$1.12M $0.82 18
2021 Q3 $164M $134M -$2.6M $0.75 17
2021 Q2 $164M $179M +$5.06M $1.00 17
2021 Q1 $162M $179M -$13.6M $1.04 13
2020 Q4 $179M $224M +$2.42M $1.26 13
2020 Q3 $177M $213M -$7.31M $1.20 13
2020 Q2 $180M $254M +$147K $1.40 16
2020 Q1 $179M $258M -$1.67M $1.44 14
2019 Q4 $180M $258M +$258M $1.43 17